Figure 3 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
<p>Prevalence of extended therapy among patients who finished 5-year adjuvant hormone therapy, by whether recommended to extend therapy by the Swedish National Clinical Guideline, 2010 to 2020. Note: 365 of 504 patients who met the criteria to extend adjuvant hormone therapy in the clinical gu...
Đã lưu trong:
| Tác giả chính: | Erwei Zeng (14958443) (author) |
|---|---|
| Tác giả khác: | Wei He (14958446) (author), Arvid Sjölander (14958449) (author), Jenny Bergqvist (14958452) (author), Kamila Czene (14958455) (author) |
| Được phát hành: |
2025
|
| Những chủ đề: | |
| Các nhãn: |
Thêm thẻ
Không có thẻ, Là người đầu tiên thẻ bản ghi này!
|
Những quyển sách tương tự
-
Figure 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Bằng: Erwei Zeng (14958443)
Được phát hành: (2025) -
Figure 2 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Bằng: Erwei Zeng (14958443)
Được phát hành: (2025) -
Figure 4 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Bằng: Erwei Zeng (14958443)
Được phát hành: (2025) -
Table 1 from Determinants and Effectiveness of Extending the Duration of Adjuvant Hormone Therapy beyond 5 Years in Patients with Breast Cancer
Bằng: Erwei Zeng (14958443)
Được phát hành: (2025) -
Figure 1 from Reduction in Vaccine HPV Type Infections in a Young Women Group (18–25 Years) Five Years after HPV Vaccine Introduction in Colombia
Bằng: Alba L. Combita (22677298)
Được phát hành: (2025)